Capstan Therapeutics scientists demonstrate that lipid nanoparticles can engineer CAR T cells within the body without ...

Memorial Sloan Kettering Cancer Center researchers have identified a metabolic switch that determines whether intestinal stem ...

From basal laminar deposits to foveal centering, a new framework refines what clinicians see—and what they treat—in outer ...

The research group led by Professor Martin Green has published Version 66 of the solar cell efficiency tables. There are 17 new results reported in the new version. Furthermore, the tables ...

Tarlatamab, a bispecific delta-like ligand 3–directed T-cell engager immunotherapy, received accelerated approval for the treatment of patients with previously treated small-cell lung cancer.

In a phase 3, randomized trial, we enrolled patients with local or regional cutaneous squamous-cell carcinoma, after surgical resection and postoperative radiotherapy, at high risk for recurrence ...

Canadian biophysicist James Till, who changed the future of medicine by proving the existence of stem cells with cell biologist Ernest McCulloch, was, by all accounts, a man of rare scientific rigour.

Candid's T-cell engager shopping spree rolls on with WuXi Biologics pact worth up to $925M As for Juri, very little is publicly known about the TCG Labs Soleil-created company.